Ventilator News and Research

RSS

Innate and adaptive immune responses to SARS-CoV-2 in convalescent children and adults

In a new study, researchers explored the systemic immune responses during the acute and convalescent phases of SARS-CoV-2 in children and adults with the same disease severity.

3 Feb 2022

Patients with severe COVID-19 may have lower oxygen requirements than previously believed

A new study, led by researchers at Uppsala University, shows that all individual patients suffering from severe COVID-19 may have lower oxygen requirements than was formerly believed. The study was conducted at a Swedish district hospital during the first wave of the pandemic in 2020.

1 Feb 2022

UAB research outlines successful xenotransplantation of genetically modified kidneys

The University of Alabama at Birmingham Marnix E. Heersink School of Medicine announces today the first peer-reviewed research outlining the successful transplant of genetically modified, clinical-grade pig kidneys into a brain-dead human individual, replacing the recipient's native kidneys.

20 Jan 2022

Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection

Researchers explored the utilities of graphene and its derivatives in combating SARS-CoV-2, highlighting its applications in the biomedical domain.

20 Jan 2022

‘Decoy’ protein mitigates lung damage, death induced by aggressive SARS-CoV-2 variants

A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease, according to a Nature Chemical Biology study from researchers at the University of Illinois Chicago.

19 Jan 2022

Study shows probiotics can reduce symptoms of COVID-19 when taken post-exposure

A new study shows how a daily use of Lactobacillus rhamnosus GG (LGG) probiotic may protect against symptom development in instances when it is used as post-exposure prophylaxis within seven days after exposure to severe acute respiratory syndrome coronavirus 2.

7 Jan 2022

Defensosomes can act as decoys to protect against SARS-CoV-2

In a new study, researchers from New York University have been examining the ability of defensosomes to combat SARS-CoV-2 infection.

22 Dec 2021

3D-printed tracheal replacement splint offers hope for treating rare developmental abnormality

Ramiah Martin isn't like other little girls, and that's perfectly fine with her mother. "She is nothing short of a miracle," Leanne Martin said of her daughter, who was facing long odds before her birth in December 2017, after being diagnosed with heart problems during a prenatal ultrasound.

21 Dec 2021

Study: Middle-aged men are more likely to die after surgery than women

Middle-aged men are around 50% more likely to die after surgery than middle-aged women, according to new research being presented at Euroanaesthesia, the annual meeting of the European Society of Anaesthesiology and Intensive Care (ESAIC), held online this year.

20 Dec 2021

Covid shots for kids are scarce — and demand is mixed — in rural Montana

When children ages 5 to 11 were approved for Pfizer's lower-dose pediatric covid-19 vaccine in November, Annie Edwards was eager to get her daughter Hannah, then 5, the shot because of underlying health conditions she has stemming from her premature birth.

16 Dec 2021

Frequent cognitive impairments after 4-month follow-up in ICU COVID-19 patients

Results from a recent observational study published in the Journal Of The Neurological Sciences found that after a 4-month follow-up, ICU patients with severe COVID-19 illness were more likely to have mild cognitive impairment with features related to a diffuse encephalopathy than patients with mild infection who do not need a ventilator. Additionally, ICU patients experienced more significant impairment in executive function. All neurological deficits involve the peripheral nervous system.

14 Dec 2021

NYU Langone Health performs second successful investigational xenotransplantation procedure

Less than two months after the first breakthrough surgery, NYU Langone Health has performed its second successful investigational xenotransplantation procedure using a genetically engineered pig kidney.

13 Dec 2021

Data science proved what Pittsburgh’s Black leaders knew: Racial disparities compound covid risk

The ferocity of the covid-19 pandemic did what Black Pittsburgh — communities that make up a quarter of the city's population — thought impossible. It shook the norms.

7 Dec 2021

Cedars-Sinai researchers uncover the cause of UTI-induced delirium

Cedars-Sinai researchers have found that blocking the action of a protein called interleukin 6 (IL-6), part of the immune system, could resolve the delirium that often accompanies urinary tract infection (UTI) in elderly patients.

2 Dec 2021

Innovative algorithm predicts COVID-related intensive care unit resource use

The COVID-19 pandemic is on the rise in many European countries, and hospitals world wide are under maximum pressure.

24 Nov 2021

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

In an attempt to study the safety and effectiveness of sotrovimab in more vulnerable patients suffering from mild to moderate symptoms of COVID-19, a multinational team of researchers conducted the COVID-19 Monoclonal antibody Efficacy Trial-Intent to Care Early (COMET-ICE) trial.

11 Nov 2021

First investigational xenotransplantation marks a major step towards adequate organ supply

The first investigational transplant of a genetically engineered, nonhuman kidney to a human body was recently completed at NYU Langone Health—marking a major step forward in potentially utilizing an alternative supply of organs for people facing life-threatening disease.

21 Oct 2021

What will it take to boost vaccinations? The scene from Kentucky’s back roads

In the end it was the delta variant that drove Rose Mitchell, 89, down the winding mountain road to the Full Gospel Church of Jesus Christ to get the shot. Her pastor, Billy Joe Lewis, had told his congregation that, No, ma'am, a covid vaccine would not leave the "mark of the beast" nor rewrite their genetic codes.

18 Oct 2021

Ondansetron use associated with increased survival in mechanically ventilated COVID-19 patients

A recent study analyzes real-world data using artificial intelligence to provide insights into using ondansetron, an antiemetic agent, among SARS-CoV-2 positive patients.

14 Oct 2021

A possible protective genetic polymorphism in COVID-19

A new study discusses the role of a mucin gene enhancer on the clinical phenotype of the COVID-19.

5 Oct 2021